# Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.

> **NCT04406545** · — · COMPLETED · sponsor: **National Institute of Cardiology, Laranjeiras, Brazil** · enrollment: 25 (actual)

## Conditions studied

- Coronavirus Infection
- Endothelial Dysfunction
- Microvascular Rarefaction

## Interventions

- **OTHER:** evaluation of skin microvascular flow and reactivity

## Key facts

- **NCT ID:** NCT04406545
- **Lead sponsor:** National Institute of Cardiology, Laranjeiras, Brazil
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-15
- **Primary completion:** 2022-01-10
- **Final completion:** 2022-01-10
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04406545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04406545, "Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04406545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*